Cancer Treatment Reviews
Volume 30, Issue 7 , Pages 643-650 , November 2004

Evaluating the role of dexrazoxane as a cardioprotectant in cancer patients receiving anthracyclines

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(04)00102-1

doi: 10.1016/j.ctrv.2004.06.002

Cancer Treatment Reviews
Volume 30, Issue 7 , Pages 643-650 , November 2004

Article Tools

* Image Usage & Resolution